About Perron Institute


About Perron Institute


About Perron Institute

The Perron Institute for Neurological and Translational Science (formerly the Western Australian Neuroscience Research Institute – WANRI) is Western Australia’s longest established medical research institute. We undertake cutting edge research on a broad spectrum of conditions including stroke, Parkinson’s, motor neurone disease, muscular dystrophy, myositis and multiple sclerosis.

One of our special strengths is the connection between the Institute’s laboratory research and its 21 specialist clinics. This multidisciplinary approach enables us to translate research outcomes into treatments aimed at providing a better quality of life for millions of people around the world who suffer with devastating neurological conditions.

In 2019, the Centre for Molecular Medicine and Therapeutics (CMMIT) opened at Murdoch University. It is a joint research centre between Murdoch University and the Perron Institute. Perron Institute Director Professor Steve Wilton is also the Director of CMMIT, and the centre shares several research groups across both locations.

Perron Institute Impact Report

Download HERE

Perron Institute News

Latest Video

Our Goals

To be an international leader in translating neurological research into treatment for the benefit of the community. MORE

Our Mission

Through a multidisciplinary and collaborative approach, we are committed to research that supports the innovative and integrated care of people with neurological conditions. MORE

Our Vision

To be recognised nationally and internationally as a leader in neurological and neuromuscular research and patient care. MORE

Our History

In 1971, Perth hosted a major international congress on muscle diseases where the idea of establishing a neuromuscular research institute in Perth was born. The culminated in the establishment in 1982 of the Australian Neuromuscular Research Institute with Professor Kakulas as its Foundation Director. MORE


The Perron Institute undertakes pioneering research on a broad spectrum of neurological disorders, including stroke, Parkinson’s disease, multiple sclerosis, spinal cord injury, brain cancer and muscle disorders including muscular dystrophy and myositis. It brings together laboratory scientists, neurologists, neurosurgeons, clinical psychologists MORE


The Perron Institute is enjoying the recent success of the US Food and Drug Administration (FDA) accelerated approval for a novel treatment for Duchenne muscular dystrophy, using “genetic patches” to mask the error in the gene message that causes Duchenne. MORE

World Leaders

Perron Institute is a world leader in Molecular Genetic therapies

Neuroscience research is entering a new and exciting era of discovery. New techniques in genetics, cell and molecular biology and neuroimaging are allowing even the most complex problems in neuroscience to be addressed, often for the first time. Problems that hitherto were thought beyond the scope of medical science are now being tackled on a regular basis, often with spectacular success. The Perron Institute’s research on a new therapy for Duchenne muscular dystrophy is a case in point. This research has established for the first time that Duchenne – a disease formerly thought hopelessly incurable – is amendable to therapy.

Ways to Support Us

Help support our groundbreaking research and clinics. You can make a single donation, arrange to donate regularly or, make a gift in your Will